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ABSTRACT
Background: Finnish men used to have higher semen quality than Danish men. However, recent studies showed that semen qual-
ity in Finland has declined, but it has been relatively stable in Denmark.
Objective: This study aimed to compare new data on semen quality of the young Finnish men to that of Danish men.
Materials and methods: In this cross-sectional study, 18- to 19-year-old men residing in Turku, Finland and Copenhagen, Den-
mark, were invited to participate in 2008–2011. Each man filled in a questionnaire, provided one semen sample and underwent
andrological examination. Semen samples were analyzed according to WHO. Multiway ANOVA was used to adjust semen variables
for duration of sexual abstinence and age (and time from ejaculation to the start of semen analysis for sperm motility).
Results: Altogether 287 Finnish men and 873 Danish men participated in the study. The adjusted median sperm concentrations
were 49 and 47 million/mL for Finnish and Danish men, respectively (p = 0.48). The adjusted median total sperm counts were 148
million in Finland and 146 million in Denmark (p = 0.87). The adjusted median percentages of morphologically normal spermatozoa
were 6.9% in Finland and 6.5% in Denmark, p = 0.27. Finnish men had higher adjusted median percentages of motile spermatozoa
(A+B+C) than Danish men (80% vs. 69%, p < 0.001). The proportion of men who had low semen quality (sperm concentration, per-
centage of morphologically normal spermatozoa or percentage of progressively motile spermatozoa below WHO reference limits)
was lower in Finland (25.4%) than in Denmark (34.6%), p = 0.004.
Discussion: Considerable percentage of men in both countries had low semen quality. The deteriorating semen quality in Finland
may result in decreasing fecundity, which is a cause of concern.
Conclusion: The formerly high semen quality in Finland has converged to the lower Danish levels. Our findings demonstrate the
importance of continuing surveillance of semen quality.
INTRODUCTION
Studies have shown geographical variation of semen quality
(Carlsen et al., 1992; Jørgensen et al., 2001, 2002; Punab et al.,
2002; Swan et al., 2003; Levine et al., 2017; Virtanen et al., 2017).
In the Nordic and Baltic regions, the East-West gradient of
semen quality was demonstrated (Jørgensen et al., 2002). Sperm
concentrations of the young men from general population in
Finland, Estonia, and Lithuania were higher than that of the
men in Norway and Denmark (Jørgensen et al., 2002; Punab
et al., 2002). Semen quality of the young Swedish men was in the
middle of this gradient (Richthoff et al., 2002). In addition to the
difference in the semen quality, men in Finland and Denmark
also have shown differences in other aspects of male reproduc-
tive health. Finland has had a low incidence of testicular cancer
compared with Denmark, which is among the countries with the
highest incidences (Adami et al., 1994; Chia et al., 2010;
Engholm et al., 2010; Znaor et al., 2014). Congenital cryp-
torchidism (Boisen et al., 2004) and hypospadias (Virtanen et al.,
2001; Boisen et al., 2005) were also reported to be more common
in Denmark than in Finland.
At an international level, significant recent trends have been
seen with regard to human semen quality and testicular cancer.
Semen quality has been shown to have declined in many areas
(Levine et al., 2017), and the incidence of testicular cancer has
been increasing (Znaor et al., 2014). These findings have also
been observed among Finnish men (Jørgensen et al., 2011). In
contrast, a recent study of young men in Denmark revealed that
semen quality in Denmark has been relatively stable between
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1996 and 2016 (Priskorn et al., 2018). To investigate these trends
further, we have conducted a semen quality study in the young
men from general population in these two countries by using
the same standardized research protocol.
MATERIAL AND METHODS
Study population
This is a cross-sectional study in the young men in two Nordic
countries—Denmark and Finland. The study was conducted at
two sites—Institute of Biomedicine, University of Turku in
Turku, Finland, and Department of Growth and Reproduction,
Rigshospitalet in Copenhagen, Denmark. The man and his
mother were born in the country of investigation, and the men
were raised there.
In Finland, men who were 18–19 years of age during the study
period and residing in Turku, Kaarina or Raisio area in the
Southwest Finland were invited to participate in this study, irre-
spective of their health status. List of the men and their
addresses were obtained from the registration authority accord-
ing to their birth years. The invitation letters were sent to their
home addresses. The men were asked to send the reply letters
stating their wish to participate or not to participate in the study.
In a case of refusal to participate, they were asked to fill in the
form about basic characteristics, including height, weight, cur-
rent home address, and occupation. In Denmark, 18- to 19-year-
old men who had no severe or chronic diseases undergo obliga-
tory medical examination for the military recruitment. Some
men postponed the examination until their studies were com-
pleted. In collaboration with the military health authority, all of
the men who lived and attended the medical examinations in
the greater Copenhagen area during the study period were
invited to participate in this study. They were invited on the day
of examinations regardless of whether they were fit for military
service. The recruitment period was from 2009 to 2011 in Turku
and autumn 2008–2011 in Copenhagen. In Turku, 289 Finnish
men participated in the study and 287 (99.3%) of them provided
semen samples. In Copenhagen, of 882 Danish participants, 873
(99.0%) provided semen samples. Participation rates were 9% in
Finland and 35% in Denmark.
The study protocol was the same as in the previous semen
quality studies of the young men in Europe with the same
research protocol for both Denmark and Finland (Jørgensen
et al., 2002; Punab et al., 2002; Paasch et al., 2008).
Questionnaire
Standardized questionnaire was created in English and trans-
lated into Danish and Finnish (Jørgensen et al., 2002). It was
subsequently back-translated into English to check for consis-
tency. The questionnaire was sent to home address of the partic-
ipant before the study visit. The questionnaire included
questions about general health, maternal history during preg-
nancy, childhood and pubertal history, education, medical con-
ditions, diseases of reproductive system and treatments, fertility,
diet, lifestyle and medications and substance use. The men were
requested to ask their mothers to help answer the questions
about their pregnancy and childhood history of the men.
On the visit day, the man came to the research center,
returned the completed questionnaire, underwent physical
examination and provided a semen sample.
Physical examination
The examination was performed by trained physicians, ten
examiners in Denmark and three in Finland. Height and weight
were measured. Body hair and the presence of gynecomastia
were evaluated. Pubic hair was assessed according to Tanner
staging system (Marshall & Tanner, 1970). Testicular size was
measured by using Prader orchidometer. Male genitalia were
examined and the abnormalities were noted.
Semen analysis
Participants were asked to abstain from ejaculation for at least
48 h before collecting semen samples. However, semen samples
collected following less than 48 h of sexual abstinence were also
accepted and included in the analysis. The abstinence period was
calculated from the time difference between previous and current
ejaculation as reported by the men. Each man provided one sam-
ple by masturbation in the private room near the andrology labo-
ratory. In Finland, semen sample collection at home was an
alternative for the men who were unwilling to collect samples at
the laboratory. In this case, a research nurse sent a container to
the participant’s home address prior to the visit day. The sample
had to be handled carefully to avoid extreme temperature or any
spillage and had to be delivered to the laboratory within one hour.
Semen samples were analyzed for semen volume, sperm con-
centration, sperm motility, and sperm morphology. There were
three technicians who analyzed semen samples in Denmark. In
Finland, one technician analyzed semen volume, sperm concen-
tration, and sperm motility, and the other person analyzed
sperm morphology.
When the semen sample was delivered to the andrology labo-
ratory, the sample was kept in 37°C incubator during liquefac-
tion. Subsequently, semen volume was estimated from the
weight of the semen by assuming that sperm density is 1 g/mL
(Auger et al., 1995). Semen weight was calculated by subtracting
weight of empty container from the weight of the same con-
tainer including semen sample. Sperm motility was assessed at
37°C with heated microscope stage at 9200 magnification. The
sperm motility was categorized as grade A, B, C, or D (World
Health Organization, 1992, 1999). The percentage of motile sper-
matozoa (grade A+B+C) and progressively motile spermatozoa
(grade A+B) were reported. For the assessment of sperm concen-
tration, samples were diluted in a solution of 0.6 mol/l NaHCO3
and 0.4% (v/v) formaldehyde in distilled water before assess-
ment. B€urker-T€urk haemocytometer (Paul Marienfeld GmbH &
Co. KG, Lauda-K€onigshofen, Germany) was used in Copen-
hagen, and improved Neubauer haemocytometer was used in
Turku. Semen was smeared, air-dried, and fixed in 95% ethanol
before Papanicolaou staining. Sperm morphology was assessed
according to the strict criteria (Menkveld et al., 1990; World
Health Organization, 2010).
External quality control for sperm concentration was per-
formed during the study period. Center in Copenhagen sent five
blinded semen samples to Turku four times per year. The techni-
cians in both countries independently checked the same sam-
ples. The results showed that the sperm concentration assessed
by the center in Turku was not significantly different from that
assessed by the center in Copenhagen (p = 0.77).
The data of the Danish men had been published previously as
a part of larger studies (Jørgensen et al., 2012; Priskorn et al.,
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2018). We included Danish data in the statistical analysis to
directly compare the results between countries, as the study pro-
tocols and semen analyses were identical.
The study protocol was approved by the institutional review
board and local ethics committee. Study was conducted accord-
ing to the Helsinki II Declaration. All participants provided writ-
ten informed consent prior to participation. All of the
participants received financial compensation, 50 Euro in Finland
and 500 DKK (approximately 67 Euro) in Denmark.
Statistical analysis
The characteristics of the participants were reported by using
the mean (SD) or median (5th and 95th percentile) for continuous
variables and percentages for categorical variables. Between-
group differences of the participants’ characteristics were
analyzed by Pearson chi-squared or Fisher’s exact test in case of
categorical variables and Student’s t-test or Mann–Whitney
U-test for continuous variables.
Multiway ANOVA was used to adjust semen parameters to the
confounding factors and to compare the results between coun-
tries, both the semen results from all men and from a subgroup
of men who did not take any medications or androgenic hor-
mones, without any past or current andrological diseases, or fer-
tility problem. Age, season, and abstinence time were tested for
confounding effect on all semen variables. In addition, the effect
of time from ejaculation to start of semen analysis was also
tested for the effect on sperm motility. Semen variables were
transformed to correct for non-normal distribution of residuals.
Semen volume was ln-transformed. Cubic root transformation
was used for sperm concentration, total sperm count, total num-
ber of morphologically normal spermatozoa, and total number
of progressively motile spermatozoa. Square root transformation
was used for percentage of spermatozoa with normal morphol-
ogy. Sperm motility was logit-transformed. Age had a positive
confounding effect on semen volume and total number of mor-
phologically normal spermatozoa. Abstinence period had
increasing effect on semen volume, sperm concentration, total
sperm count, and sperm motility. Therefore, both age and absti-
nence period were entered into final models as continuous vari-
ables. Abstinence period was entered as three continuous
variables (three linear splines): 0–48, 49–96, and more than 96 h.
Percentage of morphologically normal spermatozoa was not
influenced by any of these confounding variables. Season of
examination did not have any effect on semen variables and was
therefore not included in the final model. Time from ejaculation
to the start of semen analysis was entered into the model as two
continuous variables (two linear splines): 0–30 min and more
than 30 min. The duration of more than 30 min had a negative
confounding effect on sperm motility and was also included in
the final models of sperm motility. The interlaboratory differ-
ence of sperm concentration assessment was not included in the
final model. The estimated median semen values were reported
at a mean age, a mean abstinence period and at mean time from
ejaculation to the start of semen analysis. Analysis of the external
quality control for the assessment of sperm concentration and
the subgroup analysis of men with no andrological problem and
no medication use was also performed by using multiway
ANOVA.
Two-sided p-values of <0.05 were considered statistically sig-
nificant. For the main outcomes, which are the 8 comparisons of
the semen variables between the two countries, the Bonferroni
adjusted alpha levels of 0.006 per test (0.05/8) were used. IBM
SPSS Statistics v. 24.0 (IBM, Armonk, NY) was used for statistical
analyses.
RESULTS
Characteristics of the participants are shown in Table 1. Fin-
nish men were slightly younger, had a larger testis size, and used
less alcohol than Danish men. Similar proportion of men from
both countries reported medical health problems, except for dif-
ferences in the rate of thyroid disease and sexually transmitted
diseases. Thyroid disease was reported by three (1%) men in Fin-
land but none in Denmark. Higher percentage of men in Den-
mark reported a history of sexually transmitted infection. In
Finland, 2.4% of men reported history of Chlamydial infection
and none reported gonococcal infection. In Denmark, 10.3% of
men had had Chlamydial infection and 0.6% had had gonococ-
cal infection. Three Finnish men (1%) were operated for cryp-
torchidism. None received hormonal therapy. Fourteen Danish
men (1.6%) were treated by operation, and three men (0.3%)
received hormonal treatment for cryptorchidism. The clinical
examination showed similar findings in both countries, except
varicocoele was detected more often in the Finnish men than in
the Danish men. Gynecomastia was not detected in any men.
Higher proportion of the men in Denmark than in Finland had
history of maternal and paternal cigarette smoking during
pregnancy.
Results of the semen variables are reported in Table 2.
Adjusted semen volume, sperm concentration, total sperm
count, and percentage and total number of morphologically nor-
mal spermatozoa were not significantly different between the
two countries. Danes had lower sperm motility than Finns.
Azoospermia was identified in 3 (1%) Finnish men and 8 (0.9%)
Danish men (p = 0.85). There were 8.8% of Finnish men and
11.2% of Danish men who had sexual abstinence period less
than 48 h, p = 0.26. Subgroup analysis of the men who did not
take any medications, without any past or current andrological
diseases, or fertility problem (trying to conceive for more than
12 months without success) is also shown in Table 2. The results
from this subgroup analysis had the same direction as the analy-
sis of all men.
Distribution of semen quality based on the WHO lower refer-
ence limits is shown in Table 3 (Cooper et al., 2009; World
Health Organization, 2010). More men in Denmark had sperm
concentration less than 15 9 106/mL than in Finland (15.0%
and 9.1%, respectively, p = 0.01). Proportion of men who had
sperm concentration less than 40 million/mL in Finland was
38.6% and that in Denmark was 41.5%, p = 0.39. More men in
Finland used medications during 3 months prior to the exami-
nation than men in Denmark. When the analysis of drug use
classified according to the drug groups was made, similar pro-
portion of men in both countries used each drug class-oral
antibiotics, analgesics, antipyretics, antihistamines, inhalers for
asthma or allergic rhinitis, psychiatric and CNS-acting medica-
tions and other medications (data not shown). However, the use
of topical medications was more common in Denmark (16%)
than in Finland (9%). There were one Finnish man and four
Danish men who used supplemental androgenic hormones dur-
ing three months before the study. Fig. 1 illustrates semen qual-
ity of the participating men classified into three categories—low,
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intermediate, and high semen quality—when sperm concentra-
tion, percentage of morphologically normal spermatozoa, and
percentage of progressively motile spermatozoa were taken into
account together as described previously (Damsgaard et al.,
2016).
In Finland, a total of 104 men (3.4% of the non-participating
men) sent the letters refusing to participate in the study. The
height, weight, and body mass index of the non-participating
men were similar to the participants (data not shown).
DISCUSSION
In this study of 1160 young men from general population in
Finland and Denmark, we found that semen quality among
Danish and Finnish men was remarkably similar. Our results are
Table 1 Characteristics of the participants and self-reported medical conditions
Characteristic Median (5th–95th percentile) or percentages p-value
Finland (n = 287) Denmark (n = 873)
Age (years) 18.7 (18.5–19.1) 19.1 (18.4–23.1) <0.001a
Height (m) 1.80 (1.70–1.91) 1.81 (1.70–1.92) 0.003a
Weight (kg) 73.3 (58.5–99.4) 73.2 (60.3–96.9) 0.65a
Body mass index (kg/m2) 22.6 (18.4–30.5) 22.4 (18.8–28.7) 0.07a
Tanner stage of pubic hair
IV 3.5% 0.8% 0.01b
V 11.2% 12.1%
VI 85.3% 87.1%
Testis size by orchidometer (ml)e 24 21 <0.001a
Year of examination (%)
2008 0.0% 15.3% <0.001b
2009 44.4% 35.4%
2010 29.9% 35.5%
2011 25.7% 13.7%
Season of examination (%)
Spring 31% 34% <0.001b
Summer 17% 8%
Autumn 22% 46%
Winter 30% 12%
Duration of education (years) 11.6 12.6 <0.001d
Cigarette smokers (%)f 45.0% 49.5% 0.19b
Smoking (cigarettes/day), all men (mean (SD)) 3.3 (5.7) 4.2 (6.5) 0.12d
Smoking (cigarettes/day), only smokers (mean (SD)) 7 (1–20) 10 (1–20) 0.52a
Duration of smoking (years)g 2.0 (0.0–6.0) 2.0 (0.0–7.0) 0.56a
Alcohol consumption during past week (units) 6 (0–36) 11 (0–42) <0.001a
Diagnosed as having
Asthma (%) 9.8% 10.9% 0.66c
Diabetes (%)h 0.7% 0.0% 0.06c
Thyroid disease (%) 1.0% 0.0% 0.02c
Varicocele (%) 0.3% 0.7% 1.00c
Hydrocele (%) 1.4% 1.5% 1.00c
Testicular torsion (%) 1.0% 1.5% 0.77c
Hypospadias (%) 0.0% 0.6% 0.34c
Epididymitis/orchitis (%) 0.3% 0.9% 0.47c
Cystitis (%) 4.4% 4.0% 0.82c
Prostatitis (%) 0.8% 0.1% 0.14c
Sexually transmitted diseasesi (%) 2.1% 10.7% <0.001c
Pregnancy history
Maternal smoking during pregnancyj (%) 11.9% 24.1% <0.001b
Paternal smoking during pregnancy (%) 31.9% 42.5% 0.01b
Preeclampsia (%) 2% 2.3% 0.62b
Hypertension during pregnancy (%) 4.4% 4% 0.95b
Gestational diabetes mellitus (%) 1.6% 0.4% 0.11c
Clinical examination
Testicular position (%) 0.64c
Scrotal 100% 99.2%
Inguinal (one testis or both) 0% 0.3%
Non-palpable (one testis or both) 0% 0.5%
Epididymis abnormality (%) 2.1% 1.6% 0.60c
Varicocele (%) 20.6% 12.8% 0.004c
Hydrocele (%) 0.7% 0.7% 1.000c
Treated for
Testicular cancer 0.0% 0.1% 1.00c
Varicocele 0.3% 0.3% 1.00c
Hydrocele 1.4% 1.3% 1.00c
Cryptorchidismk 1.0% 1.9% 0.44c
aStudent’s t-test. bChi-squared test. cFisher’s exact test. dMann–Whitney U-test. eAverage size of both testes. fIncluding both current smokers and ex-smokers. gDura-
tion of smoking among cigarette smokers. hType 1 or type 2 diabetes. iIncluded gonococcal and chlamydial infection. jIncluding maternal cigarette smoking of any
duration. kTreatment for cryptorchidism were either surgery or hormones.
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interesting in relation to a recent meta-analysis of international
data demonstrating an ongoing downward trend in semen qual-
ity among Western men, which also includes Finnish men
(Levine et al., 2017).
Finnish men used to have high sperm concentration at an
international scale (Virtanen et al., 2013). A study in fertile men
in Finland, Scotland, France, and Denmark showed that the
median sperm concentration of the men from Finland was
the highest, followed by men from Scotland, France and that of
the men from Denmark was the lowest (Jørgensen et al., 2001).
Several young men studies with similar research protocol to the
present study were conducted during late 90s to early 2000s (Vir-
tanen et al., 2017). The sperm concentration was adjusted to the
abstinence period of at least 96 h. Men in Finland and Estonia
had higher adjusted sperm concentration than men in Norway
and Denmark (54, 57, 41, and 41 million/mL, respectively) (Jør-
gensen et al., 2002). The adjusted sperm concentration of young
men reported from Germany was 42–46 million/mL (Paasch
et al., 2008), Japan, 59 million/mL (Iwamoto et al., 2013), Spain,
62 million/mL (Fernandez et al., 2012), and Lithuania, 55 mil-
lion/mL (Punab et al., 2002). The recently published study in
men from Baltic countries examined during 2003–2004 reported
median sperm concentration of 63 million/mL (Erenpreiss et al.,
2017).
A relatively high level of sperm concentration in Finland was
constant during the examination years 1967 to 1994 (Vierula
et al., 1996). The participants in that study were men from infer-
tile couples. The adjusted sperm concentration in the last year of
the study was 85.2 million/ml (Vierula et al., 1996). However,
this finding does not last any longer, since the 9-year semen
quality trend study in Finland later showed that sperm
concentration of the young Finnish men declined from 67 mil-
lion/mL in examination years 1998–1999 to 48 million/mL in
2006 (Jørgensen et al., 2011). In contrast, the 21-year,
Table 2 Semen quality of the young men in Finland and Denmark
Semen parameters All men (Finland: n = 287, Denmark: n = 873) Subgroupc (Finland n = 166, Denmark: n = 465)
Observed Adjusteda p-valueb Observed Adjusteda p-valueb
Mean (SD) Median (5th-95th) Median (95%CI) Mean (SD) Median (5th-95th) Median (95%CI)
Semen volume (mL)
Finland 3.2 (1.6) 3.1 (0.9–6.4) 2.8 (2.7–3.0) 0.04 3.1 (1.5) 3.1 (0.8–6.2) 2.7 (2.5–2.9) 0.05
Denmark 3.4 (1.6) 3.2 (1.3–6.2) 3.1 (3.0–3.2) 3.3 (1.5) 3.1 (1.2–6.2) 3.0 (2.8–3.1)
Sperm concentration (9106/mL)
Finland 59 (43) 48 (9–139) 49 (44–54) 0.48 61 (42) 51 (11–139) 53 (46–61) 0.66
Denmark 61 (53) 48 (4–167) 47 (44–50) 64 (53) 52 (5–166) 51 (47–56)
Total sperm count (9106)
Finland 177 (147) 146 (14–450) 148 (132–165) 0.87 175 (128) 151 (17–454) 147 (128–169) 0.78
Denmark 197 (172) 146 (13–541) 146 (137–156) 202 (171) 157 (15–562) 151 (139–163)
Percent normal morphology (%)
Finland 7.5 (4.3) 6.5 (1.5–16.0) 6.9 (6.3–7.5) 0.27 7.7 (4.3) 7.0 (2.0–16.0) 6.9 (6.2–7.7) 0.23
Denmark 7.5 (4.8) 7.0 (0.5–16.0) 6.5 (6.2–6.8) 7.5 (4.8) 7.0 (0.5–16.0) 6.4 (6.0–6.8)
Percent A+B+C sperm motility (%)
Finland 77 (16) 82 (40–92) 80 (78–81) <0.001 78 (15) 83 (48–92) 80 (78–82) <0.001
Denmark 67 (14) 70 (40–87) 69 (68–70) 67 (14) 69 (39–87) 69 (67–70)
Percent A+B sperm motility (%)
Finland 68 (18) 75 (21–86) 70 (68–72) <0.001 69 (18) 75 (21–86) 71 (68–73) <0.001
Denmark 57 (16) 59 (28–79) 57 (56–59) 57 (16) 59 (27–79) 57 (56–59)
Total number of morphologically normal spermatozoa (9106)
Finland 14 (17) 10 (0–43) 11 (9–13) 0.38 14 (15) 9 (0–43) 10 (9–13) 0.69
Denmark 17 (21) 10 (0–60) 10 (9–11) 18 (21) 10 (0–64) 10 (9–11)
Total number of A+B motile spermatozoa (9106)
Finland 132 (114) 104 (3–336) 106 (94–120) 0.001 128 (99) 103 (4–337) 103 (89–119) 0.04
Denmark 119 (109) 89 (5–342) 84 (78–90) 121 (108) 91 (6–344) 86 (78–94)
Abstinence duration (h)
Finland 69 (24) 65 (39–117) 0.02d 67 (22) 63 (37–112) 0.001d
Denmark 74 (34) 63 (36–137) 76 (34) 65 (36–135)
Time from ejaculation to analysis (min)
Finland 45 (21) 45 (20–80) 0.003d 45 (22) 45 (20–80) 0.02d
Denmark 41 (22) 35 (15–85) 40 (23) 35 (15–90)
aSemen parameters were adjusted for abstinence duration and age. In addition, percentages of sperm motility were also adjusted for the time from ejaculation to start
of semen analysis. The adjusted estimates of the analysis of all men represented men at the mean age of 19.4 years with the mean abstinence duration of 73 h and
mean time from ejaculation to start of semen analysis of 42 min. bp-Value shown here is the p-value of the differences of the adjusted semen parameters between the
two countries. cSubgroup analysis included men who did not take any medications, androgenic hormones, without any past or current andrological diseases, or fertility
problem (trying to conceive for more than 12 months without success). dStudent’s t-test. p-Values are the differences of mean levels between countries.
Table 3 Proportions of men who had spermatozoa parameters less than
WHO lower reference value
Semen parameters Finland
(%)
Denmark
(%)
p-
value*
Sperm concentrations <15 9 106/mL 9.1 15.0 0.01
Total sperm number <39 9 106/ejaculate 12.6 14 0.56
Percentage of morphologically normal
spermatozoa < 4%
19.6 25.5 0.05
Percentage of total (A + B + C) sperm
motility < 40%
4.6 4.9 0.84
Percent of progressive AB sperm
motility < 32%
7.1 6.7 0.80
*Chi-squared test.
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prospective, cross-sectional study in Denmark revealed that
there was no persistent trend in the semen quality of the young
Danish men during the examination years 1996–2016. Now, our
study elucidated that the adverse trend of semen quality in Fin-
land resulted in similar semen quality in Finland and Denmark
in terms of sperm production capacity and percentages of sper-
matozoa with normal morphology. We found slightly better
sperm motility in Finland than in Denmark, a finding which
should be taken with some caution, as sperm motility evalua-
tions were not coordinated by a quality control system between
our two groups.
Etiologies of the declining semen quality among Finnish men
are unclear. Since the changes occurred during relatively short
period (few years), the causes may be more likely from environ-
mental factors in a broad sense than genetic causes. These may
include the man’s exposure to the endocrine disrupting chemi-
cals, stress, changing lifestyles, tobacco smoking, marijuana
smoking, alcohol consumption, diet, medication intake, or sub-
stance use (Barazani et al., 2014; Skakkebæk et al., 2015; Virta-
nen et al., 2017). The basic clinical characteristics of the Finnish
men in our study were relatively similar to the previous study
with comparable body mass index, amount of cigarette smoking,
and alcohol consumption (Jørgensen et al., 2011). Therefore,
these factors are probably not the causes of the worsening
semen quality in Finland. Subgroup analysis of men who did not
take any medications or androgenic steroids, did not have any
past or current andrological diseases, or fertility problem
resulted in the same conclusion as the analysis of all men. Thus,
the reported between-country differences cannot be explained
by these factors. There are a number of genetic defects that are
related with lowered semen quality. These include the condi-
tions related with azoospermia or oligozoospermia, such as
Klinefelter’s syndrome, Y chromosome deletions, Androgen
receptor (AR) gene mutation, Cystic fibrosis transmembrane
conductance regulator (CFTR) gene mutation, genes related with
isolated hypogonadotropic hypogonadism and genes defects
found to be associated with reduced sperm motility and abnor-
mal sperm morphology (Hotaling, 2014; Pereira et al., 2017;
Krausz & Riera-Escamilla, 2018). However, the incidence of the
genetic abnormalities should not change in few years; therefore,
genetic abnormalities are unlikely primary etiologies of the
declining semen quality.
The role of parental factors and prenatal exposures in determi-
nation of semen quality should also be considered. A significant
increase in testicular cancer, which most likely has a fetal origin,
among Finnish men has been reported (Jørgensen et al., 2011)
and it seems relevant to speculate that this change and our find-
ing of decreased semen quality may be related to common fac-
tors, which interfere with development of the fetal testis
(Skakkebæk et al., 2001). These factors include fetal exposure to
endocrine disrupting chemicals, maternal lifestyle, and health
condition during pregnancy. Recently, an association between
paternal factors, for example paternal cigarette smoking during
pregnancy, and reduced semen quality of the son has also been
shown (Axelsson et al., 2013). Thus, not only men’s current diet,
lifestyle, and environmental exposure, but also parental factors
and prenatal exposure should be taken into account as possible
determinants of semen quality. Cross-sectional studies can,
however, provide only retrospectively collected data on prenatal
factors. Such data are prone to recall bias. Therefore, birth
cohort studies with prospectively collected prenatal data are
necessary to evaluate more carefully the role of these factors on
adult male reproductive health.
Sperm concentration less than 40 million/mL relates with
impaired fecundity (Bonde et al., 1998; Guzick et al., 2001;
Slama et al., 2002). We found that a high proportion of men in
our study had sperm concentration below this level both in Fin-
land (38.6%) and Denmark (41.5%). However, it has not been
shown which single parameter can best predict fertility, as
sperm concentration, sperm morphology, and progressive sperm
motility all relate with fertility (Bonde et al., 1998; Guzick et al.,
2001). Therefore, we also reported classes of semen quality when
the three semen variables (sperm concentration, the percentage
of spermatozoa with normal morphology and progressive motil-
ity) all were taken into account, as described previously (Dams-
gaard et al., 2016; Priskorn et al., 2018). This is based on the
lower reference ranges of WHO and the threshold reported from
previous studies that showed the levels of semen variables that
are related with fecundity (Bonde et al., 1998; Guzick et al.,
2001; Slama et al., 2002). We found that a large proportion of
men in Finland (25.4%) and Denmark (34.6%) had poor semen
quality, and only 19.3% of men in Finland and 21.5% in Denmark
had good semen quality, when all three semen parameters were
taken into account (Fig. 1).
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Figure 1 Proportion of men classified as having low, intermediate, or high
semen quality based on unadjusted sperm concentration, progressive
sperm motility, and percentage of morphologically normal spermatozoa.
Low semen quality is defined as sperm concentration <15 million/mL or
progressive (A+B) sperm motility <32% or morphologically normal sperma-
tozoa <4% or as any combination of these. High semen quality is defined as
sperm concentration >40 million/mL and progressive (A+B) sperm motility
>50% and morphologically normal spermatozoa >9%. Other semen quality
results are classified as ‘intermediate semen quality’. p-values are the
between-country differences tested by chi-squared test.
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It is noteworthy that a large proportion of men in our study
did not meet the WHO-defined lower limits of semen values.
These lower reference limits are the 5th centiles of the semen
values derived from analysis of several studies in fertile men,
whose partners had time to pregnancy of 12 months or less
(Cooper et al., 2009; World Health Organization, 2010). This is a
cause of concern, because poor semen quality relates with
increased time to pregnancy and male infertility.
A strength of the present study was the study design and study
population. We used the same, standardized protocol for both
countries, which allowed us to reliably compare the results. The
population in the present study was young men unselected for
their general health, education and fertility status. The men and
their mothers were born in the country of examination, therefore
reducing the variations in ethnicity and geographical environ-
ment. Thus, participants may represent general population of
the young men in these two Nordic countries, not self-selected
due to fertility problems. The effect of potential confounding
factors to semen variables was investigated and adjusted accord-
ingly. Sperm concentration analysis was controlled under exter-
nal quality control program, except for sperm motility and
morphology, see below.
The recruitment of the men in our study was slightly different
between Finland and Denmark. In Denmark, the men who
undergo medical examination for military service had no known
severe or chronic diseases. In Finland, the invitation letters were
sent to the young men regardless of health status. However, the
questionnaire data revealed that similar proportion of participat-
ing men in both countries had particular underlying diseases as
shown in Table 1, except more men in Denmark than in Finland
had been diagnosed with sexually transmitted disease. There-
fore, we believe that the characteristics of the men from the two
countries were relatively similar. In addition, the recruitment
processes were essentially the same over the years when semen
studies were carried out in the two countries.
Our study had some limitations. It is noteworthy that the
external quality control was performed for sperm concentration,
but not for sperm morphology and sperm motility. In addition,
interobserver variation among the clinical examiners between
the countries was not studied during the project period. There-
fore, the comparison of these semen variables and the clinical
examinations between the countries should be interpreted with
some caution. In Finland, semen sample collection at home was
an alternative. This may increase the time from ejaculation to
the start of semen analysis in Finland, which probably decreases
sperm motility. Semen volume, sperm concentration, and sperm
morphology are not affected. However, in our study, the sperm
motility was higher in Finland than in Denmark, even though it
might be decreased from the longer time from ejaculation to the
start of analysis in Finland. Therefore, the collection of samples
at home does not cause major concern for the comparison of
semen variables between countries. A common problem for
population-based studies, particularly semen quality studies, is
a low participation rate, which may affect the generalization of
the results. Comparisons of the characteristics between the par-
ticipating and non-participating men might help check the risk
of selection bias. The participation rate in Finland was low;
therefore, we asked for the basic information of the non-partici-
pants to be compared with the participants. We found that the
height, weight, and body mass index reported by the 104
non-participating men who reported their basic characteristics
to the researchers were similar to the participating men. All of
them lived in the same areas in Finland as the participants. The
age range at invitation was relatively narrow (18–19 years of
age), and the men were recruited in a consecutive order accord-
ing to their date of birth. Therefore, the characteristics of the
participating and non-participating men were rather similar.
However, Denmark had higher participation rate than Finland in
the present study and the rate was also high for the previous mil-
itary conscript studies (Andersen et al., 2000; Jørgensen et al.,
2002, 2012; Erenpreiss et al., 2017). This may be due to the
recruitment methods in Denmark that the invitation to partici-
pate in the study was performed by researchers at the site of
medical examination for military service. As the data about
maternal factors and paternal smoking during pregnancy were
retrospectively collected, this information should be interpreted
cautiously.
More research to identify causes of deteriorating semen qual-
ity is needed. The effect of the endocrine disrupting chemicals
needs to be investigated further. In addition, the study of the role
of fathers on the sons’ reproductive health through spermatozoa
epigenetic mechanisms is necessary (Barratt et al., 2018; Donkin
& Barres, 2018).
CONCLUSION
In conclusion, we found that semen quality of young Finnish
men is converging toward that of Danish men. Our findings are
yet another example of deteriorating male reproductive health
and parallel to registry studies showing recent increases in tes-
ticular cancer among young Finnish men, but rather stable high
incidence of testicular cancer in Denmark. Our study did not
reveal the causes for this significant finding, which is yet another
example calling for much more research in male fertility prob-
lems, which contribute significantly to infertility and
childlessness.
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